General MedicationsINJECTIONGeneric
QUADRAMET
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
Standard Dose
50mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview QUADRAMET is listed in Drugs@FDA under application 020570 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SAMARIUM SM-153 LEXIDRONAM PENTASODIUM Form and strength INJECTABLE;INJECTION - 50mCi/ML Sponsor LANTHEUS MEDICAL Submission history Latest submission status date: 2017-09-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview QUADRAMET is listed in Drugs@FDA under application 020570 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SAMARIUM SM-153 LEXIDRONAM PENTASODIUM Form and strength INJECTABLE;INJECTION - 50mCi/ML Sponsor LANTHEUS MEDICAL Submission history Latest submission status date: 2017-09-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.